|
1 |
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors
Arnold, Lisa. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2025
|
|
|
|
2 |
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective
Kähler, Katharina C.. - Freiburg : Universität, 2024
|
|
|
|
3 |
Second opinion and self‐efficacy in German skin cancer patients
Stege, Henner Maximilian. - Freiburg : Universität, 2024
|
|
|
|
4 |
Zweitmeinung und Selbstwirksamkeit bei deutschen Hautkrebspatienten
Stege, Henner Maximilian. - Freiburg : Universität, 2024
|
|
|
5 |
Die Hautklinik Dortmund – Gestern und Heute
Enthalten in Aktuelle Dermatologie Bd. 50, 2024, Nr. 12: 548-551
|
|
|
|
6 |
„Warum Dermatologie?“ – Umfrage unter jungen Weiterbildungsassistentinnen und -assistenten in deutschen Hautkliniken
Enthalten in Aktuelle Dermatologie Bd. 50, 2024, Nr. 08/09: 403-409
|
|
|
|
7 |
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Franklin, Cindy. - Augsburg : Universität Augsburg, 2023
|
|
|
|
8 |
German S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" – long version of the update 2023
Leiter-Stöppke, Ulrike. - Augsburg : Universität Augsburg, 2023
|
|
|
|
9 |
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Kähler, Katharina C.. - Freiburg : Universität, 2023
|
|
|
|
10 |
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Heppt, Markus V.. - Augsburg : Universität Augsburg, 2023
|
|
Administration
